We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Recommends Additional Studies for High-Risk Drugs
EMEA Recommends Additional Studies for High-Risk Drugs
January 2, 2008
Sponsors wishing to test high-risk new drugs for the first time on human subjects are advised to undertake additional preliminary studies in some circumstances under a new draft guideline from the European Medicines Agency (EMEA).